British pharmaceutical giant AstraZeneca announced surging quarterly profit Thursday on strong sales of cancer drugs and as the group zones in on the United States, pressured by President Donald Trump. Net profit jumped 77 percent to $2.53 billion in the third quarter compared with the July-September period one year earlier, AstraZeneca said in a statement. […]
The New York Finance is the premier platform for bold innovation, visionary leadership, and next-generation entrepreneurship. Dive into compelling stories of emerging ventures, market game-changers, and influential leaders redefining the business landscape. Stay informed with exclusive rankings, strategic insights, and the key trends shaping the global financial future.
Never miss any important news. Subscribe to our newsletter.
Copyright 2025 - The New York Finance - All rights reserved.
Never miss any important news. Subscribe to our newsletter.
